Toronto, Canada

Sara Arab

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 7.2

ph-index = 2

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2014-2019

where 'Filed Patents' based on already Granted Patents

2 patents (USPTO):

Title: Innovating Heart Failure Assessment: The Contributions of Sara Arab

Introduction

Sara Arab, an innovative inventor based in Toronto, Canada, has made significant strides in the field of medical diagnostics. With two patents to her name, her work primarily focuses on the assessment of heart failure, utilizing novel biomarkers to enhance diagnostic accuracy and patient care.

Latest Patents

Sara's latest patents include groundbreaking methodologies in the use of specific markers for heart failure assessment. The first patent, titled "Use of Mimecan in the Assessment of Heart Failure," outlines a method for assessing heart failure in vitro by measuring the concentration of the marker mimecan in a sample. This method not only assesses mimecan levels but also allows for the measurement of other heart failure markers, such as natriuretic peptides, cardiac troponins, and inflammation markers, thereby providing a comprehensive analysis compared against established reference concentrations.

Her second patent, "Use of SFRP-3 in the Assessment of Heart Failure," introduces a similar approach, involving the measurement of the SFRP-3 marker. This patent discloses a method for quantifying the concentration of SFRP-3 and other markers in a sample, aiding in the assessment of heart failure through comparative analysis with reference populations. Both innovations include the development of kits designed for measuring mimecan and SFRP-3, making significant contributions to the field of cardiac diagnostics.

Career Highlights

Sara has gained valuable experience working with distinguished companies, including Roche Diagnostics Operations, Inc., and F. Hoffmann-La Roche AG. Her work in these organizations has provided her with the expertise needed to develop her innovative assessment methods and contribute meaningfully to medical research.

Collaborations

Throughout her career, Sara has had the opportunity to collaborate with esteemed colleagues, including Dirk Block and Georg Hess. These collaborations have played a vital role in refining her methodologies and expanding the scope of her inventions in the cardiovascular research domain.

Conclusion

Sara Arab's innovative spirit and dedication to improving heart failure diagnostics signify her important role in the medical research community. Through her patents and collaborative efforts, she is paving the way for enhanced patient assessment methods, ultimately contributing to better health outcomes for individuals suffering from heart-related conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…